174 related articles for article (PubMed ID: 37184661)
1. BAZ2A-RNA mediated association with TOP2A and KDM1A represses genes implicated in prostate cancer.
Roganowicz M; Bär D; Bersaglieri C; Aprigliano R; Santoro R
Life Sci Alliance; 2023 Jul; 6(7):. PubMed ID: 37184661
[TBL] [Abstract][Full Text] [Related]
2. BAZ2A-mediated repression via H3K14ac-marked enhancers promotes prostate cancer stem cells.
Peña-Hernández R; Aprigliano R; Carina Frommel S; Pietrzak K; Steiger S; Roganowicz M; Lerra L; Bizzarro J; Santoro R
EMBO Rep; 2021 Nov; 22(11):e53014. PubMed ID: 34403195
[TBL] [Abstract][Full Text] [Related]
3. BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrence.
Gu L; Frommel SC; Oakes CC; Simon R; Grupp K; Gerig CY; Bär D; Robinson MD; Baer C; Weiss M; Gu Z; Schapira M; Kuner R; Sültmann H; Provenzano M; ; Yaspo ML; Brors B; Korbel J; Schlomm T; Sauter G; Eils R; Plass C; Santoro R
Nat Genet; 2015 Jan; 47(1):22-30. PubMed ID: 25485837
[TBL] [Abstract][Full Text] [Related]
4. Structural basis of the TAM domain of BAZ2A in binding to DNA or RNA independent of methylation status.
Chen S; Zhou M; Dong A; Loppnau P; Wang M; Min J; Liu K
J Biol Chem; 2021 Dec; 297(6):101351. PubMed ID: 34715126
[TBL] [Abstract][Full Text] [Related]
5. BAZ2A safeguards genome architecture of ground-state pluripotent stem cells.
Dalcher D; Tan JY; Bersaglieri C; Peña-Hernández R; Vollenweider E; Zeyen S; Schmid MW; Bianchi V; Butz S; Roganowicz M; Kuzyakiv R; Baubec T; Marques AC; Santoro R
EMBO J; 2020 Dec; 39(23):e105606. PubMed ID: 33433018
[TBL] [Abstract][Full Text] [Related]
6. A novel RNA binding surface of the TAM domain of TIP5/BAZ2A mediates epigenetic regulation of rRNA genes.
Anosova I; Melnik S; Tripsianes K; Kateb F; Grummt I; Sattler M
Nucleic Acids Res; 2015 May; 43(10):5208-20. PubMed ID: 25916849
[TBL] [Abstract][Full Text] [Related]
7. Histone demethylase KDM1A represses inflammatory gene expression in preadipocytes.
Hanzu FA; Musri MM; Sánchez-Herrero A; Claret M; Esteban Y; Kaliman P; Gomis R; Párrizas M
Obesity (Silver Spring); 2013 Dec; 21(12):E616-25. PubMed ID: 23595969
[TBL] [Abstract][Full Text] [Related]
8. PHD finger protein 2 (PHF2) represses ribosomal RNA gene transcription by antagonizing PHF finger protein 8 (PHF8) and recruiting methyltransferase SUV39H1.
Shi G; Wu M; Fang L; Yu F; Cheng S; Li J; Du JX; Wong J
J Biol Chem; 2014 Oct; 289(43):29691-700. PubMed ID: 25204660
[TBL] [Abstract][Full Text] [Related]
9. TIP5 primes prostate luminal cells for the oncogenic transformation mediated by
Pietrzak K; Kuzyakiv R; Simon R; Bolis M; Bär D; Aprigliano R; Theurillat JP; Sauter G; Santoro R
Proc Natl Acad Sci U S A; 2020 Feb; 117(7):3637-3647. PubMed ID: 32024754
[TBL] [Abstract][Full Text] [Related]
10. The emerging role of histone lysine demethylases in prostate cancer.
Crea F; Sun L; Mai A; Chiang YT; Farrar WL; Danesi R; Helgason CD
Mol Cancer; 2012 Aug; 11():52. PubMed ID: 22867098
[TBL] [Abstract][Full Text] [Related]
11. MiR137 is an androgen regulated repressor of an extended network of transcriptional coregulators.
Nilsson EM; Laursen KB; Whitchurch J; McWilliam A; Ødum N; Persson JL; Heery DM; Gudas LJ; Mongan NP
Oncotarget; 2015 Nov; 6(34):35710-25. PubMed ID: 26461474
[TBL] [Abstract][Full Text] [Related]
12. BEND3 represses rDNA transcription by stabilizing a NoRC component via USP21 deubiquitinase.
Khan A; Giri S; Wang Y; Chakraborty A; Ghosh AK; Anantharaman A; Aggarwal V; Sathyan KM; Ha T; Prasanth KV; Prasanth SG
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8338-43. PubMed ID: 26100909
[TBL] [Abstract][Full Text] [Related]
13. An RNA-dependent and phase-separated active subnuclear compartment safeguards repressive chromatin domains.
Lerra L; Panatta M; Bär D; Zanini I; Tan JY; Pisano A; Mungo C; Baroux C; Panse VG; Marques AC; Santoro R
Mol Cell; 2024 May; 84(9):1667-1683.e10. PubMed ID: 38599210
[TBL] [Abstract][Full Text] [Related]
14. KDM1A triggers androgen-induced miRNA transcription via H3K4me2 demethylation and DNA oxidation.
Yang S; Zhang J; Zhang Y; Wan X; Zhang C; Huang X; Huang W; Pu H; Pei C; Wu H; Huang Y; Huang S; Li Y
Prostate; 2015 Jun; 75(9):936-46. PubMed ID: 25728837
[TBL] [Abstract][Full Text] [Related]
15. KDM1A microenvironment, its oncogenic potential, and therapeutic significance.
Ismail T; Lee HK; Kim C; Kwon T; Park TJ; Lee HS
Epigenetics Chromatin; 2018 Jun; 11(1):33. PubMed ID: 29921310
[TBL] [Abstract][Full Text] [Related]
16. Discovery of BAZ2A bromodomain ligands.
Spiliotopoulos D; Wamhoff EC; Lolli G; Rademacher C; Caflisch A
Eur J Med Chem; 2017 Oct; 139():564-572. PubMed ID: 28837921
[TBL] [Abstract][Full Text] [Related]
17. Lysine Demethylase 6B Regulates Prostate Cancer Cell Proliferation by Controlling c-MYC Expression.
Yıldırım-Buharalıoğlu G
Mol Pharmacol; 2022 Feb; 101(2):106-119. PubMed ID: 34862309
[TBL] [Abstract][Full Text] [Related]
18. The lysine specific demethylase-1 (LSD1/KDM1A) regulates VEGF-A expression in prostate cancer.
Kashyap V; Ahmad S; Nilsson EM; Helczynski L; Kenna S; Persson JL; Gudas LJ; Mongan NP
Mol Oncol; 2013 Jun; 7(3):555-66. PubMed ID: 23384557
[TBL] [Abstract][Full Text] [Related]
19. Pan-cancer and multi-omics analyses revealed the diagnostic and prognostic value of BAZ2A in liver cancer.
Liu Y; Wang J; Guo J; Zhang Q; Wang S; Hu F; Wu J; Zhao Y; Zhang J; Yu Y; Li Y; Zhang X
Sci Rep; 2024 Mar; 14(1):5228. PubMed ID: 38433277
[TBL] [Abstract][Full Text] [Related]
20. Kdm1a promotes SCLC progression by transcriptionally silencing the tumor suppressor Rest.
Jin Y; Ma D; Gramyk T; Guo C; Fang R; Ji H; Shi YG
Biochem Biophys Res Commun; 2019 Jul; 515(1):214-221. PubMed ID: 31146914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
